Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load

Bone Marrow Transplantation

Volumn 26, Issue 2, 2000, Pages 199-201

  Hoshino, Y ^c   Kimura, H ^d   Kuzushima, K ^d   Tsurumi, T ^d   Nemoto, K ^a   Kikuta, A ^a   Nishiyama, Y ^d   Kojima, S ^d   Matsuyama, T ^b   Morishima, T ^d  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

EBV; Lymphoproliferative disorders; Specific immunity; Viral load

Indexed keywords

CD8 ANTIGEN; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS LOAD;

EID: 0033944929     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702492     Document Type: Article

References (10)

1. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
2. Kimura H, Morita M, Yabuta Y et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132-136.
3. Kuzushima K, Nakamura S, Nakamura T et al. Increased frequency of antigen-specific CD8+ cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J Clin Invest 1999; 104: 163-171.
4. Lucas KG, Burton RL, Zimmerman SE et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 1998; 91: 3654-3661.
5. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
6. Rooney CM, Smith CA, Ng CY et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549-1555.
7. Heslop HE, Li C, Krance RA et al. Epstein-Barr infection after bone marrow transplantation. Blood 1994; 83: 1706-1708.
8. Khatri VP, Baiocchi RA, Peng R et al. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder. J Immunol 1999; 163: 500-506.
9. Rees L, Thomas A, Amlot PL. Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet 1998; 352: 789.
10. Hoshino Y, Morishima T, Kimura H et al. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 1999; 163: 5735-5740.